USA – Loxo Oncology, an Eli Lilly and Company R&D group, and Foghorn Therapeutics Inc have collaborated to develop oncology medicines using Foghorn’s Gene Traffic Control platform. Located in Cambridge,…
Read MoreEli Lilly, Foghorn enter into pact to develop genetic cancer treatments
